Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke.
Levy, D E
Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. [electronic resource] - Stroke Feb 1994 - 291-7 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0039-2499
10.1161/01.str.25.2.291 doi
Adult
Age Factors
Aged
Analysis of Variance
Aspirin--therapeutic use
Brain Ischemia--blood
Cerebral Hemorrhage--etiology
Female
Fibrinogen--analysis
Heparin--therapeutic use
Humans
Hypertension--complications
Male
Middle Aged
Pilot Projects
Recombinant Proteins--adverse effects
Retrospective Studies
Sex Factors
Thrombolytic Therapy--adverse effects
Tissue Plasminogen Activator--adverse effects
Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. [electronic resource] - Stroke Feb 1994 - 291-7 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0039-2499
10.1161/01.str.25.2.291 doi
Adult
Age Factors
Aged
Analysis of Variance
Aspirin--therapeutic use
Brain Ischemia--blood
Cerebral Hemorrhage--etiology
Female
Fibrinogen--analysis
Heparin--therapeutic use
Humans
Hypertension--complications
Male
Middle Aged
Pilot Projects
Recombinant Proteins--adverse effects
Retrospective Studies
Sex Factors
Thrombolytic Therapy--adverse effects
Tissue Plasminogen Activator--adverse effects